The Na 1 -Ca 21 exchanger (NCX) regulates intracellular calcium homeostasis. We report on an upstream region of the rat NCX1 multipartite promoter that is active in cardiac myocytes. Although inactive in most non-cardiac cell lines, its activity can be rescued by cotransfection with GATA-4 and -6, but not GATA-5 transcription factors. In transgenic mice and similar to endogenous NCX1 mRNA expression, the upstream promoter region directs uniform b-galactosidase expression in cardiac myocytes from ,7.75 dpc. In adult mouse hearts, promoter activity is, however, significantly reduced and heterogeneous, except in the conduction system (sinoatrial and atrioventricular node, atrioventricular bundles). The upstream NCX1 promoter region thus directs appropriate spatial and temporal control of cardiac expression throughout development. Published by Elsevier Science Ireland Ltd.
Introduction
The Na 1 -Ca 21 exchanger (NCX), a ubiquitously expressed plasma membrane transporter, regulates and maintains intracellular calcium homeostasis (Schulze et al., 1993) . In adult heart, up to a third of systolic Ca 21 can be removed by the NCX, but its relative contribution to relaxation is greatest in fetal or hypertrophied myocytes (Bers, 1991; Studer et al., 1997) . Effectively, the exchanger provides a mechanism to extrude the amount of Ca 21 that enters the cell via the sarcolemmal voltage dependent Ca 21 -channel (Bridge et al., 1990; Wier, 1991) .
Isoforms of the NCX are produced from RNAs encoded by separate genes (NCX1, NCX2 and NCX3) (Li et al., 1994; Nicoll et al., 1996; Barnes et al., 1997; Quednau et al., 1997) . Transcripts coding for the NCX are present in developing hearts by 10ED in rat (Koban et al., 1998) and at 7.75-8.0 dpc in mouse (Koushik et al., 1999) , making this transcript one of the earliest markers of cardiac differentiation. Although NCX1 gene transcripts are abundant in embryonic/fetal hearts, mRNA abundance decreases during the post-natal period, but increases in senescence and disease (Kent et al., 1993; Studer et al., 1994; Menick et al., 1996; Yoshiyama et al., 1997; Koban et al., 1998) . The decrease in NCX mRNA abundance after birth is regulated transcriptionally (Koban et al., 1998) .
Multiple gene transcripts arise from NCX1 either by alternative splicing of the COOH terminus of the large intracellular loop or by use of at least three alternative promoters that can be viewed as components of one multipartite promoter (Lee et al., 1994; Gabellini et al., 1995; Quednau et al., 1997) . The multipartite promoter contains multiple transcription start sites, located over a region of approximately 35 kb and some 30 kb upstream of the first coding exon (Kraev et al., 1996; Barnes et al., 1997; Scheller et al., 1998) . Leader sequences generated from these promoter regions are composed of unique 5 0 untranslated and alternatively used exons, 1a/Br1, 1c/Kc1 or 1d/Br2 (Quednau et al., 1997; Koban et al., 1998) . The 5 0 mRNA variants show tissue-restricted patterns of expression: Br2/1d and Kc1/1c are primarily expressed in heart and kidney, respectively. The tissue-restricted expression of these untranslated exons suggests that alternative promoter regions of the multipartite promoter might regulate tissue-specific gene expression (Lee et al., 1994) . Low, but quantifiable expression of NCX1 transcripts with a 'cardiac' leader sequence (exon Br2/1d) have, however, been reported in brain and kidney (Lee et al., 1994; Scheller et al., 1998) . The region located upstream of the 'cardiac-restricted' exon Br2/1d is currently thought to be the most distant portion of the multipartite promoter. This distant promoter region located ,70 kb upstream of the first coding exon has been isolated and sequenced (Koban et al., 1998; Nicholas et al., 1998; Scheller et al., 1998) . In our analysis of this sequence from rat, we identified three proximal and four distal consensus GATA-binding sequences (Koban et al., 1998) . Others have identified two proximal GATA sites, a serum-response element (2107), an E-box and a potentially MEF2-like element that are functional regulatory elements (Nicholas et al., 1998; Cheng et al., 1999) . In cat, transient transfection studies of a minimal 'cardiac' promoter region (sequences 2184 to 1172 from cat or 2137 to 185 from rat) were sufficient to drive transcription in neonatal rat cardiac myocytes. GATA-4 was subsequently shown to regulate the NCX1 'cardiac' promoter in vitro (Cheng et al., 1999; Nicholas and Philipson, 1999) . Regulatory ciselements necessary for in vitro transcriptional activation in neonatal rat cardiac myocytes are therefore present in the proximal 'cardiac' NCX1 promoter.
We examined the activity of this distant upstream NCX1 promoter region in several cell lines and the role of GATA transcription factors -4, -5, and -6 in regulating the activity of this promoter in vitro. We subsequently hypothesized that this GATA-binding site-rich promoter region would direct cardiac-restricted gene expression in vivo in the absence of the full multipartite promoter. To test this hypothesis, we prepared transgenic mice with the distant upstream 'cardiac' NCX1 promoter region linked to a LacZ expression cassette and examined its expression throughout development.
Results

Transfection studies in vitro
The 2.73 kb NCX1 promoter region located upstream of the 1d/Br2 exon displayed strong promoter activity in cultured primary cardiac myocytes. Transactivation events were seen with all of the deletion constructs examined, except for the 223 NCX1 construct (Fig. 1) . Promoter activity was limited to cardiac myocytes, and no activity was detected in fibroblasts isolated from the hearts. In serum containing medium, the reporter activity was greater with the 2330 NCX1 construct but, in defined medium, four promoter constructs showed similar activity. Luciferase activity was least with the 2540 promoter construct. Only the 21660 to 22100 region showed significant differential (down-) regulation in serum compared to defined medium.
Luciferase activity was ,10% of that seen with the control vector pGL3-prom in all cell lines examined, except for NRK52E cells (Fig. 2) . The 2330 and 22100NCX1 promoters displayed 13 and 40% of control vector activity in these cells. GATA-4 and -6, but not GATA-5 transcription factors could activate the 22800NCX1 and 2330NCX1 promoter construct in PC12, NRK52E, L6E9 and C2C12 cells (Fig. 2) . Reporter activity was, in general, greatest when cotransfected with GATA-6 expression vectors, but did not differ from negative controls with GATA-5 ðn ¼ 4Þ. GATA-4 and -6 transcription factors were more effective at transactivating NCX1 promoter constructs in C2C12 myoblast than in any of the other cell lines tested. The ability of GATA transcription factors to bind to consensus GATA-binding sequences in the rat promoter, including the G3 cassette that is uniquely present in the rat promoter was tested. The G1, G2 or G3 cassettes (Table 1) were incubated with nuclear extracts to assay for GATA binding (Fig. 3A) . Complex b was detected with the G1 oligonucleotide cassette, similar to the ones observed with the G3 cassette and the BNP GATA element (Bhavsar et al., 2000) . G2 formed a complex with mobility similar to that of complex b but with a much lower intensity than that identified with G1 and G3. Complex b was successfully competed by the addition of unlabelled G1, G2 and BNP cassettes (data not shown). The addition of an Oct-1 cassette or oligonucleotide cassettes containing base pair changes within the GATA sequence (G1m, G2m, G3m) were unable to compete for complex b. The G3 cassette formed one other specific complex (complex a). This complex was not disrupted by mutations within the GATA element or by the addition of GATA-specific antibodies (Fig. 3) .
The anti-GATA-4 antibody resulted in the formation of a complex with a lower mobility (ss) and the removal of most, but not all of complex b (Fig. 3A) . A supershift could not be detected with the anti-GATA-6 antibody alone, but when GATA-4 and GATA-6 antibodies were added together, complex b could no longer be detected. Both the G1 and G3 cassettes formed complexes with extracts from GATA-4 or GATA-6 overexpressing cells with migration patterns similar to that of complex b (Fig. 3B) . Addition of the anti-GATA-4 antibody resulted in a supershift, while the anti-GATA-6 antibody disrupted the formation of the complexes (Fig. 3C ).
Transgenic mice
Twenty-two founder lines were generated. NB1 mice consisted of four lines, two of which revealed LacZ expression. NB2 mice consisted of nine lines, with five expressing LacZ. Whole-mount assays indicated that surface b-galactosidase staining was virtually identical in young adult NB1 and NB2 mice lines (aged 2-3 months): staining intensities were homogeneous in the atria and ventricles (Fig. 4B) . Each of the transgenic lines had five to eight copies of the construct, limiting the possibility that differences in gene expression could be due to copy number. The NB3 and NB4 mice consisted of four and five lines, respectively. Of these, two from each line had LacZ expression (Fig. 4B) . Inconsistent mosaic patterns of staining, however, were seen in young adult hearts from NB3 and NB4 mouse lines. No further analyses were performed on the NB3 and NB4 mouse lines. It is unclear if the shorter constructs were more susceptible to the chromosomal context in which they were placed, or if some important regulatory elements necessary for sustained and robust expression in heart were missing from these promoter fragments.
Prior to formation of the cardiogenic plate, at 6.5-7 dpc, LacZ expression was not detected. In the presomite embyro (,7.75-8 dpc) , the precardiac mesoderm is part of the visceral wall of the coelom. b-galactosidase staining was unambiguous and uniform in the precardiac myocytes on both sides of the developing embryo at ,8 dpc and in the horseshoe-shaped cardiogenic plate at ,8.5 dpc (Fig. 5A-C) . bgalactosidase staining was homogeneous throughout the developing atrial and ventricular regions of the embryonic hearts ( Fig. 5D-E) . In serial sections of multiple NB1 mice aged ,14.5-16 dpc, the atrial myocardium and the trabeculated portion of the free atrial wall, the ventricular free wall, ventricular trabeculae and intraventricular septum had uniform b-galactosidase activity ( Fig. 5F-I ). The atrioventricular (AV) valves, vessels and pericardium, however, did not have detectable LacZ gene expression.
In neonatal transgenic NB mouse hearts, the activity of bgalactosidase was uniform and similar in intensity to that seen during fetal heart development ( Fig. 6A,B) . At 2-4 months of age, b-galactosidase activity continued to be detectable throughout the atria and ventricles, but was heterogeneous (Fig. 6C,D) . No differences in staining intensity and pattern of staining could be seen within or between atria and ventricles. The fibrous AV valves and coronary vessels had no detectable LacZ expression (Fig. 6B,E) . By quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) (Q-PCR), we also demonstrated that transcripts for b-galactosidase decreased by .10-fold between 9-day and 3-month-old mice. At 6-8 months of age, staining was much weaker and more diffuse in the atria and ventricles. At this time, myocardial staining was often undetectable. Only tissues associated with the conduction system continued to have strong staining, and the supraventricular b-galactosidase staining was present in all of the NB mice lines analyzed ( Fig. 6F) . Consistent with the decreased b-galactosidase staining and mRNA abundance with age, the amounts of endogenous NCX1 mRNAs were significantly reduced ðP , 0:05Þ. Maximal expression was seen during the perinatal period and was mimimal at 7 months of age (Fig. 6G) .
Cardiac conduction tissues are more densely innervated than other regions of the heart, and are known to have acetylcholinesterase activity. Using an acetylcholinesterase assay to identify conduction tissues, we were able to demonstrate that the entire conduction system of adult NB mice contained b-galactosidase activity, even as the surrounding myocytes lost LacZ expression. This was true for the sinoatrial (SA) and AV pacemaker cells, and especially for conduction tissues of the AV (His) bundle and bundle branches (Fig. 7) . The SA node is located in the region where the superior vena cava enters the right atrium. At The actual cassettes used in the experiments were double-stranded formed by annealing both sense and antisense oligonucleotides. Changes in the base-pair sequences are indicated in bold by the lower case letters. Other DNA sequences (cassettes) used in EMSA assays have been described (Bhavsar et al., 2000) . this site, LacZ expression was seen where acetylcholinesterase activity was greatest. This was also true for the cells of the AV node. In the AV bundle, LacZ expression was markedly elevated relative to the surrounding myocardium and was higher than that observed in nodal tissues. In neonatal mouse hearts, it was not possible to distinguish b-galactosidase activity in the conduction system from the activity in surrounding myocardium because of the dark and homogeneous staining throughout the heart at this time.
Although the 'cardiac' NCX1 promoter showed strong temporal and spatial regulation of the LacZ transgene in heart, low levels of expression were detectable and subsequently confirmed to be present elsewhere in the mouse. By RT-PCR analysis, NB1 and NB2 mice lines had b-galactosidase mRNA transcripts in heart, brain and liver (subsequently shown to be gall bladder) (Fig. 8A) . In adult mouse brain, LacZ expression was prominent in the choroid plexus of the lateral, third and fourth ventricles of adult mice (Fig.  8C) . The first detectable staining of the choroid plexus (right lateral recess of the fourth ventricle and lateral ventricles) was seen after 16 dpc. The pyramidal cells of Ammon's horn in the adult mouse hippocampus also had weak, but detectable b-galactosidase activity in the CA1-CA4 regions (Fig. 8D ). This pattern of staining was consistent across serial sections, and could be seen as light blue staining of Ammon's horn. At higher magnifications, the staining was visible in individual pyramidal cells. This result was confirmed by RT-PCR analysis: signals were only detected in microdissected hippocampus of LacZ 1/2 animals ðn ¼ 3Þ. b-galactosidase staining was not detectable in the hippocampus of late fetal NB mice. The lumen of the gall bladder, but not liver, had strong LacZ expression (Fig. 8E) , and was confirmed by whole-mount staining and by RT-PCR analyses. Finally, blue staining was detected in kidney and intestine in late fetal stages and adults, but based on RT-PCR analyses was determined to be non-specific. By Western blot, the b-galactosidase protein was not detectable in any tissue other than heart (Fig. 8B) , indicating that LacZ expression in tissues other than heart was very low.
Discussion
In vitro promoter activity
In cardiac myocytes, the region from 2336 to 145 Table 1 .
contains cis-elements that modulate the activity of the rat 'cardiac' NCX1 promoter, and its regulation in vitro depends on GATA transcription factors (this paper) (Barnes et al., 1997; Nicholas et al., 1998; Cheng et al., 1999; Nicholas and Philipson, 1999) . Data supporting GATA4 transcription factor binding to G1-and G2-like cassettes and experiments showing that NCX1 promoter activity is repressed by mutations to these sites have previously been described (Barnes et al., 1997; Cheng et al., 1999; Nicholas et al., 1998) . We demonstrate for the first time that both GATA-4 and -6 transcription factors can bind to three endogenous GATA-elements in the rat proximal promoter. Anti-GATA-4 and anti-GATA-6 antibodies are also able to supershift or disrupt electrophoretic mobility shift assay (EMSA) complex formation between nuclear extracts and cassettes containing consensus GATA sites. In the cat promoter, the 2185 rat GATA analogue is not conserved, perhaps accounting for some of the differences in NCX1 mRNA abundance seen in response to phenylephrine or with development (Menick et al., 1996; Reinecke et al., 1997; Golden et al., 2000) . The activity of this promoter region was relatively poor in all non-cardiac cell lines tested, except for the NRK52 kidney epithelial cells. In non-cardiac cell lines, 'cardiac' NCX1 promoter activity could be 'rescued' by cotransfection with expression vectors for GATA-4 and, especially GATA-6. Transactivation by GATA-5 was minimal and not significantly greater than that seen with the negative controls. GATA-4-6 are thought to be important for the formation of heart, gut and blood vessels (Arceci et al., 1993; Kuo et al., 1997; Molkentin et al., 1997) . Overlapping, but not identical, patterns of expression of GATA-4-6 may therefore be important for NCX1 promoter activity (Arceci et al., 1993; Molkentin et al., 1997) . In chick, depletion of one GATA factor does not affect cardiac development, but depletion of all three GATA factors leads to defects in heart morphogenesis (Jiang et al., 1998) . Furthermore, the absence of GATA-4 and -6 affects ANP and BNP gene expression similarly (Charron et al., 1999) , while preferential regulation of a-MHC, b-MHC and cardiac troponin I is seen with GATA-4. Differential gene control by GATA factors thus might prove important for the in vivo regulation of NCX1, not only in cardiac myocytes of ventricle and atria, but also in the specialized cells of the ventricular conduction tissues.
A role for multiple, and as yet, uncharacterized regulatory elements in the distal 'cardiac' NCX1 promoter region is suggested by our in vitro results. The 2330NCX1 construct displays the lowest activity in cell lines, but the highest activity in cardiac myocytes, indicating the potential for negative cis-acting elements within this region. Transcriptional activity in cell lines, by contrast, is greatest with the 22100NCX1 construct. The reporter activity of constructs 2330 to 22800, as described in Fig. 1 , does not, however, differ enough (,2.4-fold-1.5-fold) to assume that 2330NCX1 construct is always the strongest in cardiac myocytes. In cardiac myocytes, a serum-dependent inhibitory element may also be present between 21600NCX1 and 22100NCX1, but the data presented in this paper, while suggestive, are insufficient to make a definitive conclusion. 
In vivo promoter activity
The activity of the 22628 or 22091 portion of the 'cardiac' NCX1 promoter is first detected in the developing cardiogenic plate and is robust throughout embryonic and fetal development. The promoter's ability to drive transgene expression in the developing heart is independent of copy number, and because of the number of independent transgenic mouse lines examined, its activity is, for the most part, independent of chromosomal position. All LacZ expressing NB1 and NB2 mouse lines examined had five to eight copies of the transgene inserted at different locations in the genome. The promoter is specific to and active in all cardiac myocytes during embryonic and early fetal stages and does not show gradients of expression in myocardium. Importantly, both the activity of the promoter and the abundance of NCX1 mRNA transcripts decrease in heart with aging, indicating that all the information necessary for transcriptional regulation of early, perinatal and adult myocardium can be found in the rat 'cardiac' NCX1 promoter. Few transgenic markers are known that are selectively expressed in the myocardial conduction system. In adult mice, 'cardiac' NCX1 promoter driven LacZ expression is prominent in AV bundles, bundle branches and is elevated in the SA and AV nodes. This differential level of expression could not be demonstrated with surrounding myocytes in fetal or perinatal heart samples. Because the conduction system is the first part of the heart to stop proliferation, it is possible that expression of this transgene becomes frozen and remains throughout cardiac development. The promoter's activity in the remainder of the myocardium, however, diminishes with age. This pattern of expression differs markedly from our previous results (Moorman et al., 1995) , where SERCA2 mRNA transcripts were apparently absent from the AV bundles. The presence of NCX1 transcripts in cells lacking SERCA2 mRNAs is consistent with the differential expression demonstrated by these two gene products with development, aging and disease. In general, when NCX1 transcripts are abundant, SERCA2 transcripts are not abundant. Because the promoters for these two genes are so very different (Wankerl et al., 1996; Koban et al., 1998) , it is difficult to say what factor(s) may be responsible for this differential pattern of expression, particularly since perinatal SERCA2 expression is regulated post-transcriptionally (Ribadeau-Dumas et al., 1999) . The continued activity of the NCX1 promoter in the ventricular conduction tissues and persisting 'primary' myocardium of adult hearts may have functional implications for automaticity and conductivity (Huser et al., 2000) .
The nearly ubiquitous presence of NCX1 mRNA transcripts outside of the heart in adult mice (Koushik et al., 1999) , excluding perhaps some transcripts found in choroid plexus, hippocampus and gall bladder, probably reflects transcriptional activation of other regions of the multipartite . At 4 months of age (C, D), the interventricular septum (IVS), right and left ventricular free wall and atria no longer stain homogeneously for bgalactosidase activity, while an age matched control heart from a ROSA26 mouse (inset in C) showed homogeneous staining. No staining was ever detected in the coronary vessels (E). In 8-month-old NB mouse hearts (F), b-galactosidase activity is weak and diffuse in atria and ventricles but is prominent in the ventricular conduction system. Panel (G) shows a Q-PCR analysis of endogenous NCX1 (100 bp), b-galactosidase (b-gal) (137 bp) and Calsequestrin (Csq) (308 bp) transcripts. Graph of NCX1 mRNA abundance (arbitrary units, a.u.) with age and normalized to endogenous calsequestrin. RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; IVS, intraventricular septum; AV, atrioventricular; Ao, aorta; NTC, no template control; ND, neonatal day; mo, month.
NCX1 promoter. For example, endogenous NCX is unevenly distributed throughout the brain (Reuter and Porzig, 1995; Yu and Colvin, 1997) . In this study, LacZ expression was first seen in brain in the choroid plexus around 16-16.5 dpc. The choroid plexus produces cerebrospinal fluid and plays a major role in moving ions. The first evidence of choroid plexus formation is at 12.5-13 dpc, and it gradually increases in volume until ,16.5 dpc (Kaufman, 1992) . At this time, it is probably of considerable functional importance, consistent with the first detectable expression of LacZ in this location. LacZ expression was also seen in hippocampus, but only in adult mice. These findings demonstrate that the 'cardiac' NCX1 promoter must contribute to the expression of NCX1 transcripts in limited regions of brain only. The remainder of the multipartite promoter, including potentially uncharacterized regions, must play the predominant role in regulating overall expression in brain and other tissues outside of the heart. In conclusion, the 'cardiac' NCX1 promoter contains the sequence information for appropriate spatial and temporal expression of the NCX in myocardial cells, both in vitro and in vivo. In vitro, the zinc-finger transcription factors GATA-4 and -6, but not GATA-5 can rescue the activity of this promoter in non-cardiac cells. The generation of transgenic mice revealed that a 2091 bp fragment was sufficient to confer cardiac specificity to a LacZ reporter transgene during embryonic and fetal development. Additionally, it contained all the sequence information necessary to regulate transgene expression during post-natal and adult life in a manner consistent with endogenous NCX1 mRNA expression. Expression in the adult heart was most pronounced in nodal cells and ventricular conduction tissues. This promoter may therefore be of value for the identification of transcriptional mechanisms involved in the process of cardiac development and aging, and in cardiac hypertrophy and failure. Because of the strong activity of this distant upstream promoter region in the developing heart, we predict that this promoter will be useful for transgenic studies where high levels of uniform gene expression are needed throughout the fetal myocardium.
Experimental procedures
Promoter-reporter constructs
A 2.8 kb PstI fragment, containing 2730 bp of the upstream region and 45 bp of the cardiac-specific exon was cloned in pGL3basic luciferase reporter vector (Promega) (Koban et al., 1998) . For transgenic mice, the PstI fragment was cloned upstream of a LacZ construct from pNASSb (Clontech). Truncated constructs were also prepared. The coactivator expression vectors and pCG GATA-4 (rat GATA4), pcDNA3 GATA-5 (Durocher et al., 1997) and pCS21 GATA6 (human GATA6) were the kind gifts of Mona Nemer (Montreal, Canada) and Adrian Bomford (London, UK), respectively.
Cell culture
Isolation (Iwaki et al., 1990) and cultivation (Wankerl et al., 1996) of primary neonatal cardiac myocytes from Sprague-Dawley rats were performed as described. PC12 cells (rat adrenal pheochromocytoma cells) were cultured in growth medium (Dulbecco's modified Eagle medium (DMEM) with 2 mM l-glutamine, 1X anti-mycotic/antibiotic agent) supplemented with 10% fetal bovine serum (FBS) and 5% horse serum (HS). For neuronal-like cells, PC12 cells were cultured for 3 days in the medium containing 10 ng/ml nerve growth factor (2.5S-NGF, Sigma). One day before transfection, 4 £ 10 5 and 6 £ 10 5 PC12 cells were plated on laminin coated dishes for non-differentiated and differentiated cells, respectively. The rat kidney epithelial cell-line NRK52E was maintained in growth medium supplemented with 10% FBS and non-essential amino acids (Sigma) and 2 £ 10 5 cells/plate were used for transfections. Rat skeletal muscle derived L6E9 and mouse C2C12 cells were cultured as myoblasts in growth medium containing 10% FCS. For myoblasts and myotubes transfections, approximately 2.5 £ 10 5 and 4.5 £ 10 5 cells were plated per dish, respectively. COS-1 cells were grown in maintenance medium with 5% FBS and 4.5 £ 10 5 cells/plate were plated for transfections.
Transfections
Plasmids were prepared using anion-exchanger columns (Qiagen). All cells were transfected in duplicate using the calcium phosphate precipitation technique, except for PC12 cells (Wankerl et al., 1996) . PC12 cells were transfected using SuperFecte (Qiagen) according to the manufacturer's protocol. Transfections were performed with 8 mg reporter plasmid and 2 mg pON249 (LacZ expression vector). In cotransfection experiments, 7.5 mg coactivator expression plasmids, 2 mg NCX1 reporter vector and 0.5 mg pON249 were used. b-galactosidase activity was measured in micro- titer plates as described (Wankerl et al., 1996) and luciferase activity was measured in a Turner luminometer.
Nuclear extracts and mobility shift assays
Nuclear protein was extracted from ,10 6 neonatal cardiac myocytes, and either transfected or untransfected COS-1 cells and C2C12 myoblasts as described (Bhavsar et al., 2000) . EMSA binding reactions were performed with 4 mg nuclear extract, 1 mg poly[dI-dC]·[dI-dC], and 10 fmol of an end-labeled oligonucleotide double-stranded DNA cassette. The binding buffer used for the G1, G2 and G3 cassettes contained 15 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonicacid (HEPES) (pH 7.9), 40 mM NaCl, 10 mM ethylenediaminetetraacetic acid (EDTA) and 5 mM dithiothreitol (DTT) Supershift assays were performed by adding 1 or 2 ml of a polyclonal antibody specific to GATA-4, -5 or -6 (Santa Cruz) and competitions performed in the presence of a 100-fold excess of unlabeled oligonucleotide DNA cassette (Table 1) .
Generation and analysis of transgenic mice
Linearized DNA was prepared for pronuclear injection by agarose gel electrophoresis, electroelution, and chromatography on Elutip-D columns, followed by dialysis against injection buffer. DNA was injected at a concentration of 3-5 mg/ml into the pronuclei of day 1 (B6D2F1 £ B6C3F1) fertilized mouse embryos by the NIA Transgenic and Knock-out Facility Section (Baltimore, MD, USA). All animal research conformed to 'Animals in Intramural Research Guidelines' and were reviewed and approved by the Animal Care and Use Committee at the NIH/NIA. Founder mice (50% C57Bl/6, 25% DBA, 25% C3A mice) were identified by a PCR-based technique. LacZ positive founder mice were mated with B6C3F1 mice and heterozygote mice analyzed.
Mouse perfusions and histological staining
Timed-pregnancies were identified by detection of a vaginal plug, and noon was considered as 0.5 dpc. Adult mice were anesthetized with Avertin (0.6 mg/g BW) and transcardially perfused with phosphate buffered saline (PBS), pH 7.4, followed by perfusion with PBS/4% paraformaldehyde. Excised tissues were post-fixed in 4% paraformaldehyde. Mouse embryos and unperfused hearts were also washed and fixed in 4% paraformaldehyde. After fixation, embryos were transferred to a 15% sucrose solution, then to 15% sucrose/7% gelatin. The embedded embryo, hearts and organs were frozen in isopentane super-cooled by liquid nitrogen and stored at 2808C. Serial sections of 10-20 mm were made using a cryostat microtome (Microm Heidelberg). Sections were fixed in 2% paraformaldehyde/ 0.2% glutaraldehyde, stained for b-galactosidase activity and counterstained with Nuclear Fast Red or Eosin. Fixed tissues were placed in X-gal color reagent (in PBS: 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 1 mM MgCl 2 , 0.1% Tween 20, 1 mg/ml X-gal) overnight at 378C. Organs were post-fixed in 4% paraformaldehyde.
To test for the presence of acetylcholinesterase (ElBadawi and Schenk, 1967) , unfixed cryosections (14 mm thick) were incubated for 2 h at 378C in a staining solution containing 0.5 mg/ml acetyl thiocholine iodide, 65 mM sodium acetate, pH 6.0, 5 mM sodium citrate, 3 mM copper sulfate and 0.5 mM potassium ferricyanide. The reaction was stopped by washing in distilled water for 1 min. Sections were counterstained with modified Harris' Hematoxylin (Sigma).
RT-PCR analyses
Total RNA was prepared (Koban et al., 1998) and RT reactions performed with 10 pmols reverse primer and 5.0 units of Tth-Polymerase (Promega). DNA amplifications (40 cycles) were performed after addition of chelating buffer and 10 pmols forward primer (10 pmol) to the RT reaction mix. PCR amplifications were for 1 min at 958C, 30 s at 658C and 30 s at 728C. The forward/reverse primers for b-tubulin and LacZ were TCACTGTGCCTGAACTTACC/GGAA-CATAGCCGTAAACTGC and TAGCGATAACGAGC-TCCTGCA/CCTGACTGGCGGTTAAATTGC, respectively. Fragments were 317 and 351 bp, respectively. For quantitative RT-PCR reactions, 1 mg of total RNA (normalized conditions) was reverse transcribed with random hexonucleotides (PE Applied Biosystems). Real-time PCR reactions were performed with an ABI PRISM 7900 Sequence Detector System (PE Applied Biosystems) using SybrGreen protocol in a 384-well plate format. Primers for real-time Q-PCR were as follows: NCX1 forward: CAGCTTCCAAAACT-GAAATCGA, reverse: GTCCCTCTCATCAACTTCCA-AAA; and calsequestrin forward: TGAACTTCCCCACG-TACGATG, reverse: AAACTCAATCGTGCGGTCACC. Each 20 ml reaction contained 1.6 ml of a cDNA mixture, 0.4 pmol primers, 0.8 mM dNTP's, 3 mmol MgCl 2 and 1 U Ampli-Gold Taq polymerase (PE Applied Biosystems). Amplification conditions were determined for each primer set. Three independent negative controls were run for every assay, all assays were run in duplicate or triplicate and PCR products were verified by agarose gel electrophoresis. Fluorescent signals were regarded as positive if the fluorescence intensity was 10-fold greater than the standard deviation of the baseline fluorescence. Standard curves were generated from 10-fold cDNA dilutions by SDS 2.0 software. The threshold cycle (Ct) of each sample was transformed to the log of the dilutions and normalized according to the equation for each standard curve.
Western blots
Protein preparations were performed as described (Koban et al., 1998) . Fifty micrograms of protein were loaded onto gels, and transferred to Immobilon-P PVDF membranes. Membranes were incubated with a polyclonal rabbit anti-b-galactosidase antibody (5 0 -3 0 ). A horseradish-peroxidase coupled secondary antibody (goat anti-rabbit, Zymed) was added and b-galactosidase detected using ECL-reagent (Pierce). PVDF membranes were stained with Pierce Gelcode Blue Stain Reagent to ensure equal loading in each well.
Statistical analysis
All data are presented as mean^SEM and compared using an unpaired Student's t test for single comparisons with the control. Significance was taken at P , 0:05.
